Indomethacin patent ductus arteriosus prophylaxis in the modern era: renal implications

J Perinatol. 2023 Aug;43(8):1045-1046. doi: 10.1038/s41372-023-01681-w. Epub 2023 Apr 21.

Authors

Heidi J Steflik¹, Luke A Wessler², William W Shugart², Carol L Wagner³, David T Selewski³, Katherine E Twombley³, Jill C Newman⁴, Andrew M Atz³, David J Annibale³

Affiliations

¹ Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA. [email protected].
² College of Medicine, Medical University of South Carolina, Charleston, SC, USA.
³ Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA.
⁴ Department of Medicine, Medical University of South Carolina, Charleston, SC, USA.

PMID: 37085522
DOI: 10.1038/s41372-023-01681-w

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Ductus Arteriosus*
Ductus Arteriosus, Patent* / drug therapy
Ductus Arteriosus, Patent* / prevention & control
Humans
Indomethacin / therapeutic use
Infant, Newborn
Infant, Premature
Kidney
Persistent Fetal Circulation Syndrome* / drug therapy

Substances

Indomethacin